Throughout 2021, we have seen significant growth in this sector mainly due to company expansions, investments, and the ever-evolving COVID-19 vaccine journey. COVID-19 has affected, and will continue to affect, the Pharmaceutical industry in Ireland in a number of ways for the next number of years. One such change will be encouraging more collaboration between organisations for the greater good. Cross-industry and cross-enterprise collaboration in areas such as research an development is highly common, as we all continue to tackle the global pandemic. This will result in candidates having to be open to contract work as they may be required to work on projects continuously.
The theme of sustainability within Pharmaceutical sectors has never been more important. For many years larger organisations have been realising the fact that environmental policies and energy efficiencies within processing is directly related to the bottom line. Reducing energy costs, carbon footprint and waste during the process of pharmaceuticals can have a significant impact on the profitability of a facility. Additionally, as Pharmaceutical manufacturers and their clients’ supply chains becomes more and more entwined they find themselves under increased pressure to reduce their carbon footprint.